PlainRecalls

Rising Pharmaceuticals, Inc.

Compiled from official public sources by the publisher.

6 recalls on record · Latest: Jul 1, 2020

Subscribe to new Rising Pharmaceuticals, Inc. recalls (RSS)

Agency notice ledger

Federal filing book Rising Pharmaceuticals, Inc. LIGHT-BOOK · SINGLE-AGENCY

#2,274 of 14,151 · 6 notices · 0.006% archive

  • BOOK 6 notices
  • RANK #2,274 of 14,151
  • SHARE 0.006% archive
  • AGENCY FDA Drug (6)
  • CAT drugs
  • CATS 1 category
  • LATEST Jul 1, 2020
  • PHOTO 1908 Brands

Nearest notice-volume peer: 1908 Brands (0 notice gap)

Rising Pharmaceuticals, Inc. accounts for about 0.006% of the 104,423-notice archive on 6 distinct filings — a mid share signal beside absolute volume. FDA · CPSC · USDA FSIS · NHTSA notice stamps for this firm. Read with this firm → · Dominant category → · Similar-volume firm →

Where Rising Pharmaceuticals, Inc. sits among 14,151 recalling firms

Rising Pharmaceuticals, Inc. ranks 2,274th of 14,151 tracked firms by distinct recall-event count. Archive size reflects filing volume, not inherent product danger.

Rising Pharmaceuticals, Inc. vs all firms by recall-notice count

Where this firm's archive sits among every tracked recalling manufacturer

6 2274th of 14151 higher than 11,804 of 14,151 firms

Firms, banded by distinct federal recall-event inventory

Each bar is a band; taller bars hold more firms. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source FDA · CPSC · USDA FSIS · NHTSA federal recall filings · 2026-09-15

Rising Pharmaceuticals, Inc. in the notice-volume neighbourhood

Distinct federal recall events among this firm and nearest nationwide peers

notices

What this shows Rising Pharmaceuticals, Inc. holds about 0.006% of archive notices alongside 6 distinct filings.

Source FDA · CPSC · USDA FSIS · NHTSA filings aggregated by PlainRecalls As of September 2026
FDA Drug Low Jul 1, 2020

Timolol Maleate USP, 0.5%, 5 mL, Sterile Opthalmic Solution, Rx Only, For Topical Application in the Eye, Distributed by: Rising Pharmaceuticals, Inc. Saddle Brook, NJ 07663, Manufactured by: FDC Limited B-8, MIDC Industrial Area, Waluj, Aurangbad - 431 136 Marahastra, India, NDC 64980-514-05
FDA Drug Low Jul 1, 2020

Timolol Maleate Sterile Opthalmic Solution,USP 0.25%, 5 mL, Rx Only, For Topical Application, Distributed by: Rising Pharmaceuticals, Inc. Saddle Brook, NJ 07863, Manufactured by: FDC Limited B-8, MDC Industrial Area, Waluj, Aurangabad - 431-136 Maharashtra, India, NDC 64980-513-05
FDA Drug Moderate Mar 27, 2019

Valsartan Tablets 40 mg USP, 30 tablet bottles, Rx, Only, Distributed by: Acetris Health, LLC, Saddle Brook, NJ, Manufactured by: Aurolife Pharma LLC, Dayton, NJ ---- NDC 52343-122-30
FDA Drug Moderate Mar 27, 2019

Valsartan Tablets 320 mg USP, 90 tablet bottles, Distributed by: Acetris Health, LLC, Saddle Brook, NJ 07663, Manufactured by: Aurolife Pharma LLC, Dayton, NJ 08810 --- NDC 52343-125-90
FDA Drug Moderate Mar 27, 2019

Valsartan Tablets 80 mg USP, 90 tablet bottles, Rx only, Distributed by: Acetris Health, LLC, Saddle Brook, NJ 07663, Manufactured by: Aurolife Pharma LLC, Dayton, NJ 08810 --- NDC 52343-123-90
FDA Drug Moderate Mar 27, 2019

Valsartan Tablets 160 mg USP, 90 tablet bottles, Rx only, Distributed by: Acetris Health, LLC, Saddle Brook, NJ 07663, Manufactured by: Aurolife Pharma LLC, Dayton, NJ 08810 ---- NDC 52343-124-90

Rising Pharmaceuticals, Inc. holds a measurable archive slice

Drug and device firms outside this manufacturer and state, matched by notice volume and category footprint.

Similar recall count

Nearest multi-notice firms by distinct-event totals (6 here).

1908 Brands 6 Abbott Molecular 6 Accriva Diagnostics, Inc. 6 Advance Medical Designs, Inc. 6 Agave Dream 6

Similar drugs volume

Nearest multi-notice firms in the same narrow category lane.

Aire-Master of America Inc 6 Apollo Care 6 Aspen Biopharma Labs Pvt., Ltd. 6 Ben Venue Laboratories Inc 6

Frequently Asked Questions

How many federal recall notices name Rising Pharmaceuticals, Inc.? ▼
PlainRecalls indexes 6 distinct federal recall events naming Rising Pharmaceuticals, Inc., aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (archive as of September 2026). That count is an issuance inventory, not a hazard score.
Where does Rising Pharmaceuticals, Inc. sit among other recalling firms? ▼
Rising Pharmaceuticals, Inc. ranks #2,274 of 14,151 by distinct recall-event count among 14,151 firms in this archive (83rd percentile of firms with fewer notices). Rank tracks filing frequency, not product danger.
Which agency issues most of Rising Pharmaceuticals, Inc.'s notices? ▼
FDA Drug accounts for 6 of this firm's 6 indexed notices.
What product category dominates Rising Pharmaceuticals, Inc.'s filing book? ▼
Filings for Rising Pharmaceuticals, Inc. span 1 product category, led by drugs. Browse that category archive for peer firms and related notices.
Is a higher notice count more dangerous? ▼
No. Archive size reflects how often federal agencies publish recalls naming the firm — reporting volume, coverage, and product range all move the number. Always verify the individual notice with the issuing agency before acting on a specific product.
Rising Pharmaceuticals, Inc.: 6 federal recall notices aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (lead agency FDA Drug). Verify individual notices with FDA directly before acting on a specific recall.

Firm-level totals aggregate distinct federal recall events naming Rising Pharmaceuticals, Inc.; individual notices remain authoritative on each linked recall page.

Methodology · Corrections · FDA · CPSC · USDA FSIS · NHTSA · Archive as of September 2026